Home/Filings/4/0001179110-19-011975
4//SEC Filing

Ryll Thomas 4

Accession 0001179110-19-011975

CIK 0000855654other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:23 PM ET

Size

5.2 KB

Accession

0001179110-19-011975

Insider Transaction Report

Form 4
Period: 2019-11-20
Ryll Thomas
VP, Technical Operations
Transactions
  • Award

    Stock Option (right to buy)

    2019-11-19$3.48/sh+110,950$386,106110,950 total
    Exercise: $3.48From: 2020-11-19Exp: 2029-11-19Common Stock (110,950 underlying)
Footnotes (1)
  • [F1]Exercisable as to 25% of the shares on the first year anniversary of the grant, and 6.25% quarterly for the subsequent three years.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001701531

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:23 PM ET
Size
5.2 KB